Who
Anders Ekblom
Director
Company insider
Files Form 4 as: Director, Mereo BioPharma Group.
In numbers
- Trades disclosed
- 8
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 8 Feb 2024
- Last trade
- 26 Feb 2026
- Last filed
- 27 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Feb 2026filed 27 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —133,560 | filing |
| 26 Feb 2026filed 27 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —66,000 at $0.00 | filing |
| 26 Feb 2026filed 27 Feb 2026 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —133,560 | filing |
| 5 Feb 2025filed 6 Feb 2025 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —55,000 at $0.00 | filing |
| 5 Feb 2025filed 6 Feb 2025 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,054 | filing |
| 8 Feb 2024filed 9 Feb 2024 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 8 Feb 2024filed 9 Feb 2024 | MREO Mereo BioPharma Groupoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,471 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.